Graham Partners, a private equity firm, completed an investment in Rhythmlink, a medical device manufacturing company. Financial terms were not disclosed. “We’re excited about this next phase of Rhythmlink. Graham is an excellent partner for us because of their experience in medical technology and healthcare, and we see this as a growth opportunity for us to continue to innovate beyond our current capabilities. I’m extremely proud of how far we’ve come, and this is a chance for Rhythmlink to expand our business without sacrificing what matters to us – improving patient care in our field of neurodiagnostics,” Shawn Regan, Graham CEO and Co-Founder.